Cargando…
Device Thrombogenicity Emulation: An In Silico Predictor of In Vitro and In Vivo Ventricular Assist Device Thrombogenicity
Ventricular assist devices (VAD), a mainstay of therapy for advanced and end-stage heart failure, remain plagued by device thrombogenicity. Combining advanced in silico and in vitro methods, Device Thrombogenicity Emulation (DTE) is a device design approach for enhancing VAD thromboresistance. Here...
Autores principales: | Chiu, Wei Che, Tran, Phat L., Khalpey, Zain, Lee, Eric, Woo, Yi-Ren, Slepian, Marvin J., Bluestein, Danny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393420/ https://www.ncbi.nlm.nih.gov/pubmed/30814674 http://dx.doi.org/10.1038/s41598-019-39897-6 |
Ejemplares similares
-
Device Thrombogenicity Emulation: A Novel Method for Optimizing Mechanical Circulatory Support Device Thromboresistance
por: Girdhar, Gaurav, et al.
Publicado: (2012) -
Mild Paravalvular Leak May Pose an Increased Thrombogenic Risk in Transcatheter Aortic Valve Replacement (TAVR) Patients-Insights from Patient Specific In Vitro and In Silico Studies
por: Kovarovic, Brandon J., et al.
Publicado: (2023) -
Thrombogenic and Inflammatory Reactions to Biomaterials in Medical Devices
por: Labarrere, Carlos A., et al.
Publicado: (2020) -
Anti-thrombogenic coatings for devices in neurointerventional surgery: Case report and review of the literature
por: Henkes, Hans, et al.
Publicado: (2019) -
Nanomedicine for the reduction of the thrombogenicity of stent coatings
por: Karagkiozaki, Varvara C, et al.
Publicado: (2010)